Intravitreal conbercept improves outcome of proliferative diabetic retinopathy through inhibiting inflammation and oxidative stress

氧化应激 炎症 糖尿病性视网膜病变 前列腺素E2 内科学 化学 前列腺素 糖尿病 药理学 医学 内分泌学
作者
Jian-Ping Xia,Shengqiang Liu,Shuai Wang
出处
期刊:Life Sciences [Elsevier]
卷期号:265: 118795-118795 被引量:26
标识
DOI:10.1016/j.lfs.2020.118795
摘要

Conbercept is a newly-developed anti-vascular endothelial growth factor (VEGF) drug. This study aimed to evaluate the effects of conbercept on inflammation and oxidative response in proliferative diabetic retinopathy (PDR). Morphology changes in retinal microvasculature of PDR patients were determined by optical coherence tomographic angiography (OCTA). The mice were injected with streptozocin (STZ) for 20 weeks to induced PDR, then the changes in inflammatory factors, oxidative response and histological analysis were examined with Elisa assay, real time-PCR and commercial kits analysis. Conbercept treatment significantly alleviated the retinal pathological changes and significantly reduced intercellular cell adhesion molecule-1 (ICAM-1), macrophage inflammatory protein-1 (MIP-1), IL-1β, IL-6 and TNF-α protein levels but not prostaglandin E1 (PGE1), prostaglandin E2 (PGE2) and prostaglandin F2a (PGF2a) levels, all of which were remarkably elevated in aqueous fluid of PDR patients compared with non-PDR subjects. Meanwhile the inhibitory effects of conbercept on these inflammatory factors were proved by RT-PCR assays in mice experiments. And the inflammatory signal such as p-IKBα and p-p65 was correspondingly inhibited by conbercept in STZ-treated mice. Conbercept treatment significantly elevated the aqueous glutathione level of PDR patients and inhibited NOX-1, NOX-4 and ph22phox mRNA expressions and ROS production of PDR mice. Ki67 immunofluorescence staining showed that conbercept inhibited endothelial cell proliferation in retina of PDR mice. In conclusion, conbercept significantly inhibited the angiogenesis, inflammation and oxidative response in PDR mice, and these findings further reveals the molecular mechanisms of conbercept in treating PDR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
机械腾发布了新的文献求助10
刚刚
Cymatics发布了新的文献求助10
刚刚
舒服的吗喽完成签到 ,获得积分20
刚刚
无敌小汐发布了新的文献求助10
刚刚
大气指甲油完成签到,获得积分10
1秒前
membrane应助成就曼安采纳,获得10
1秒前
开心千青完成签到,获得积分10
2秒前
犹豫的踏歌完成签到,获得积分10
2秒前
fannyeast完成签到,获得积分10
2秒前
椿上春树完成签到,获得积分10
2秒前
sb发布了新的文献求助10
2秒前
LionontheMars完成签到,获得积分10
3秒前
Tina完成签到 ,获得积分10
3秒前
思源应助niuyangyang采纳,获得10
3秒前
愉快的宛儿完成签到,获得积分10
3秒前
江江完成签到,获得积分10
3秒前
May发布了新的文献求助10
4秒前
尘缘完成签到,获得积分10
4秒前
如此纠结完成签到,获得积分10
4秒前
专一的新之完成签到 ,获得积分10
5秒前
彬墩墩完成签到,获得积分10
5秒前
5秒前
大模型应助ling采纳,获得30
6秒前
linxi完成签到,获得积分10
6秒前
无趣养乐多完成签到 ,获得积分10
6秒前
LionontheMars发布了新的文献求助10
6秒前
小盆呐完成签到,获得积分10
7秒前
s6238983完成签到,获得积分10
7秒前
顾矜应助wetcue采纳,获得10
8秒前
Ava应助XunlongJi采纳,获得10
9秒前
9秒前
9秒前
奋斗尔安应助刘澄伊采纳,获得10
10秒前
烜66发布了新的文献求助10
10秒前
oyc完成签到,获得积分10
11秒前
我是老大应助坦率的松采纳,获得10
11秒前
橙子完成签到 ,获得积分10
11秒前
11秒前
smile完成签到 ,获得积分10
12秒前
wangruiyang完成签到 ,获得积分10
13秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
The Conscience of the Party: Hu Yaobang, China’s Communist Reformer 600
Geochemistry, 2nd Edition 地球化学经典教科书第二版,不要epub版本 431
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3298999
求助须知:如何正确求助?哪些是违规求助? 2934058
关于积分的说明 8466290
捐赠科研通 2607414
什么是DOI,文献DOI怎么找? 1423664
科研通“疑难数据库(出版商)”最低求助积分说明 661661
邀请新用户注册赠送积分活动 645286